Vis enkel innførsel

dc.contributor.authorKhoje, Abhijit Datta
dc.contributor.authorCharnock, Colin
dc.contributor.authorWan, Baojie
dc.contributor.authorFranzblau, Scott
dc.contributor.authorGundersen, Lise-Lotte
dc.date.accessioned2011-09-23T09:04:32Z
dc.date.available2011-09-23T09:04:32Z
dc.date.issued2011-04-20
dc.identifier.citationKhoje, A.D., Charnock, C., Wan, B., Franzblau, S. & Gundersen, L-L. (2011). Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines; imidazopyridines, pyrrolopyridines, benzimidazoles and indoles. Bioorganic & Medicinal Chemistry, 19, 3483-3491en_US
dc.identifier.issn0968-0896
dc.identifier.otherFRIDAID 801764
dc.identifier.urihttps://hdl.handle.net/10642/952
dc.description.abstract6,9-Disubstituted purines and 7-deazapurines are known to be powerful inhibitors of Mycobacterium tuberculosis (Mtb) in vitro. Analogs modified in the six-membered ring (imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles) were synthesized and evaluated as Mtb inhibitors. The targets were prepared by functionalization on the bicyclic heterocycle or from simple pyridines. The results reported herein, indicate that the purine N-1, but not N-3, is important for binding to the unknown target. The 3-deazapurines appears to be slightly more active compared to the parent purines and slightly less active than their 7-deazapurine isomers. Removal of both the purine N-3 and N-7 did not result in further enhanced antimycobacterial activity but the toxicity towards mammalian cells was increased. Both 3-deaza and 3,7-dideazapurines exhibited a modest activity against of the Mtb isolate in the state of non-replicating persistence.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesBioorganic & Medicinal Chemistry;19
dc.subjectTuberculosisen_US
dc.subjectHeterocyclesen_US
dc.subjectDeazapurinesen_US
dc.subjectVDP::Matematikk og Naturvitenskap: 400::Kjemi: 440::Organisk kjemi: 441en_US
dc.titleSynthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines; imidazopyridines, pyrrolopyridines, benzimidazoles and indolesen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionNOTICE: this is the author’s version of a work that was accepted for publication in Bioorganic & Medicinal Chemistry. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Bioorganic & Medicinal Chemistry, 19, 2011. http://dx.doi.org/10.1016/j.bmc.2011.04.023en_US
dc.identifier.doihttp://dx.doi.org/10.1016/j.bmc.2011.04.023


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel